Omnicell | OMCL - 销售收入



金融业
股票价格
USD
资产
USD 2B
现金及等价物
USD 292.17M
销售成本
USD 159.27M
流动资产
USD 735.39M
流动负债
USD 447.44M
债务
USD 202.18M
EBIT
USD 36.32M
EBITDA
USD 67.23M
员工
3.67K
EPS每股收益
USD 0.94
股本和储备
USD 1.29B
销售毛利
USD 152.94M
债务利息支出
USD 431K
贷款资金
USD 168.2M
市值
USD 1.54B
净收入
USD 24.29M
营业费用
USD 275.89M
营业利润
USD 36.32M
普通股股本
USD 45.48M
PE价格收益
42.07
税前利润
USD 16.91M
销售收入
USD 312.21M
销售和管理费用
USD 100.19M
股票
USD 96.72M
贸易债权人
USD 49.78M
应收帐款人
USD 227.05M


销售 更改 日
AppLovin 1.92B 80M 2026-06
Becton, Dickinson and Co. USD 5B 300M 2026-06
Cardinal Health USD 63.7B 2.8B 2026-06
Cerillion plc GBP 18.01M 6.39M 2026-03
Healthcare Services USD 466.68M 2.34M 2025-12
HealthStream USD 79.71M 3.24M 2025-12
HeartBeam USD 0 0 2025-03
IQVIA Holdings USD 4.37B 220M 2026-06
McKesson USD 105.38B 13.08B 2026-06
Nebius Group 399M 171.3M 2026-03
Omnicell USD 312.21M 2.33M 2026-06
Stanley Black & Decker USD 4B 150M 2026-06
Steris USD 1.5B 90M 2026-06
Veeva Systems USD 927.96M 45.02M 2026-06
Veradigm USD 142.52M 9.38M 2022-12